<DOC>
	<DOCNO>NCT02981836</DOCNO>
	<brief_summary>The purpose study evaluate protective effect , safety immunogenicity live attenuate varicella vaccine healthy child .</brief_summary>
	<brief_title>A Blind , Randomized Controlled Study Live Attenuated Varicella Vaccines</brief_title>
	<detailed_description>This study randomize , blind , control phase III clinical trial . The purpose study evaluate protective effect , safety immunogenicity live attenuate varicella vaccine manufacture Sinovac ( Dalian ) Vaccine Technology Co. , Ltd . The control diluent lyophilize vaccine manufacture Sinovac ( Dalian ) Vaccine Technology Co. , Ltd. All participant healthy , randomly assign experimental group control group ratio 1:1 .</detailed_description>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy volunteer 1 12 year old ; Proven legal identity ; Guardian ( ) volunteer and/or volunteer capable understanding write consent form , form sign volunteer include study ; Prior vaccination varicella vaccine history varicella zoster virus ( VZV ) infection ; Axillaty temperature &gt; 37.0 Â°C ; History allergy vaccine vaccine ingredient , serious adverse reaction ( ) vaccination , urticaria , difficulty breathing , angioneurotic edema , abdominal pain , etc ; History epilepsy , seizures convulsion , family history mental illness , autoimmune disease immunodeficiency ; Severe malnutrition , congenital malformation , developmental disorder , serious chronic disease ; Acute disease acute stage chronic disease within 7 day prior study entry ; Receipt follow product : 1 . Any subunit vaccine inactivate vaccine within 7 day prior study entry ; 2 . Any live attenuate vaccine within 1 month prior study entry ; 3 . Any blood product , immunosuppressant , hormone , investigational medicine ( ) within 30 day prior study entry ; Any significant abnormity heart , lung , skin , pharynx ; Any factor suggest volunteer unsuitable study base opinion investigator ;</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>live attenuate varicella vaccine</keyword>
	<keyword>protective effect</keyword>
	<keyword>safety</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>child</keyword>
</DOC>